Theo Brandt-Sarif, MD is a seasoned pharmaceutical physician who obtained his medical degree at the University of the Witwatersrand in South Africa, and his MBA at the Wharton School. He has been consulting to clinical research and clinical operations since 1999, with a focus on medical monitoring and accelerating recruitment into clinical trials.
Dr. Brandt-Sarif most recently led a team that shaved off three months from a phase 3 trial of a biologic in cancer. Consulting clients have included Pfizer, Schering-Plough, Merck, Hoffman La Roche, Gilead, Genentech, Medimmune, Boehringer-Ingelheim, Chiron, Achaogen, Rempex, Intermune and VI Technologies.